|
Total no. of diabetic patients registered
|
4,404
|
|
Type of diabetes, n (%):
| |
|
Type 1
|
54 (1.2%)
|
|
Type 2
|
4,350 (98.8%)
|
|
Age in years, median (IQR)
|
53 (46 to 60)
|
|
Age group in years, n (%):
| |
|
≥39
|
438 (10.0%)
|
|
40 to 49
|
1,168 (26.5%)
|
|
50 to 59
|
1,540 (35.0%)
|
|
≥60
|
1,258 (28.6%)
|
|
Women, n(%)
|
2,905 (66.0%)
|
|
Origin of patients*, n (%):
| |
|
District of clinic
|
1,724 (41.2%)
|
|
Other districts of province
|
1,550 (37.0%)
|
|
Outside province
|
912 (21.8%)
|
|
Random plasma glucose on admission, median (IQR)
|
272 (196 to 376)
|
|
Random plasma glucose <180 mg/dl, n (%)
|
797/4,095 (19.5%)
|
|
HbA1c on admission %, median (IQR) (n = 950)
|
11.5 (9.1 to 13.5)
|
|
HbA1c <7%, n (%)
|
59/950 (6.2%)
|
|
Blood pressure on admission, n (%):
| |
|
Systolic ≥140 mm Hg
|
1,555/3,840 (40.5%)
|
|
Diastolic ≥90 mm Hg
|
1,316/3,840 (34.3%)
|
|
BMI on admission, kg/m2, median (IQR) (n = 4337):
| |
|
All patients
|
23.5 (20.9 to 26)
|
|
Men
|
23 (20.1 to 26)
|
|
Women
|
23.7 (21.1 to 26.2)
|
|
BMI ≥23 kg/m2, n (%)
|
2,433/4,337 (56.1%)
|
|
BMI ≥27.5 kg/m2, n (%)
|
686/4,337 (15.8%)
|
|
Treatment on last consultation, n (%):
| |
|
No antidiabetic drug
|
91 (2.2%)
|
|
Oral antidiabetic drug(s) alone
|
3,911 (94.1%)
|
|
Insulin alone
|
115 (2.8%)
|
|
Oral antidiabetic drug(s) plus insulin
|
41 (1.0%)
|
|
No data
|
246
|
